These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37748556)

  • 1. Best practices in the treatment of melasma with a focus on patients with skin of color.
    Desai SR; Alexis AF; Elbuluk N; Grimes PE; Weiss J; Hamzavi IH; Taylor SC
    J Am Acad Dermatol; 2024 Feb; 90(2):269-279. PubMed ID: 37748556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma.
    Basit A; Rahman A; Uddin R
    J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Efficacy Of 35% Glycolic Acid Peel vs. Jessner Peel as an Adjuvant to Topical Triple Combination (2% Hydroquinone, 0.025% Tretinoin, 0.01% Fluocinolone Acetonide) Therapy in Melasma Females Cases.
    Modi A; Parmar S; Marfatiya Y
    J Cosmet Sci; 2021; 72(4):418-431. PubMed ID: 35262482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma.
    Grimes PE; Bhawan J; Guevara IL; Colón LE; Johnson LA; Gottschalk RW; Pandya AG
    J Am Acad Dermatol; 2010 Jun; 62(6):962-7. PubMed ID: 20398959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical metformin in the treatment of melasma: A preliminary clinical trial.
    Banavase Channakeshavaiah R; Andanooru Chandrappa NK
    J Cosmet Dermatol; 2020 May; 19(5):1161-1164. PubMed ID: 31502392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A histological examination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% cream.
    Bhawan J; Grimes P; Pandya AG; Keady M; Byers HR; Guevara IL; Colón LE; Johnson LA; Gottschalk R
    Am J Dermatopathol; 2009 Dec; 31(8):794-8. PubMed ID: 19755910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melasma in Latin America: options for therapy and treatment algorithm.
    Cestari T; Arellano I; Hexsel D; Ortonne JP;
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):760-72. PubMed ID: 19646135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
    Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S
    J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma.
    Chan R; Park KC; Lee MH; Lee ES; Chang SE; Leow YH; Tay YK; Legarda-Montinola F; Tsai RY; Tsai TH; Shek S; Kerrouche N; Thomas G; Verallo-Rowell V
    Br J Dermatol; 2008 Sep; 159(3):697-703. PubMed ID: 18616780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
    Taylor SC; Torok H; Jones T; Lowe N; Rich P; Tschen E; Menter A; Baumann L; Wieder JJ; Jarratt MM; Pariser D; Martin D; Weiss J; Shavin J; Ramirez N
    Cutis; 2003 Jul; 72(1):67-72. PubMed ID: 12889718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of hydroquinone by Raman spectroscopy in patients with melasma before and after treatment.
    Cabrera-Alonso R; Guevara E; Ramírez-Elías MG; Moncada B; González FJ
    Skin Res Technol; 2019 Jan; 25(1):20-24. PubMed ID: 29790609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy.
    Cestari TF; Hexsel D; Viegas ML; Azulay L; Hassun K; Almeida AR; Rêgo VR; Mendes AM; Filho JW; Junqueira H
    Br J Dermatol; 2006 Dec; 156 Suppl 1():13-20. PubMed ID: 17176300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives of topical formulations for melasma.
    de Freitas ACP; Rigon RB; Bagatin E; Leonardi GR
    Int J Dermatol; 2023 Feb; 62(2):260-268. PubMed ID: 36083295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
    Grimes PE
    Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream.
    Torok HM
    Am J Clin Dermatol; 2006; 7(4):223-30. PubMed ID: 16901182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of fluocinolone acetonide, hydroquinone, and tretinoin cream in chinese patients with melasma: a randomized, double-blind, placebo-controlled, multicenter, parallel-group study.
    Gong Z; Lai W; Zhao G; Wang X; Zheng M; Li L; Yang Q; Dang Y; Liu L; Zou Y
    Clin Drug Investig; 2015 Jun; 35(6):385-95. PubMed ID: 25989732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
    Grimes P; Watson J
    Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma.
    Torok HM; Jones T; Rich P; Smith S; Tschen E
    Cutis; 2005 Jan; 75(1):57-62. PubMed ID: 15732437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical therapies for melasma.
    Mahajan VK; Patil A; Blicharz L; Kassir M; Konnikov N; Gold MH; Goldman MP; Galadari H; Goldust M
    J Cosmet Dermatol; 2022 Sep; 21(9):3707-3728. PubMed ID: 35854432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of a fixed combination of hydroquinone/tretinoin/fluocinolone cream compared with hydroquinone alone in the treatment of melasma.
    Cestari T; Adjadj L; Hux M; Shimizu MR; Rives VP
    J Drugs Dermatol; 2007 Feb; 6(2):153-60. PubMed ID: 17373174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.